Shire PLC (ADR) - SHPG - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Shire PLC (ADR) - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
SHPG	Nasdaq	2834	http://www.shire.com	95.28 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Shire PLC (ADR) Shire Rises On Unusually High Volume (SHPG) - May 20th, 2013 1:50 pm 5 Drugs Stocks On The Rise - May 20th, 2013 11:03 am Shire advances after report renews takeover speculation - May 20th, 2013 8:03 am Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases - May 20th, 2013 5:00 am Leerink estimates Shire takeout value at least $110 per share - May 20th, 2013 4:30 am Shire may return cash to thwart takeover, Daily Mail reports - May 20th, 2013 4:25 am Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting - May 17th, 2013 8:00 am SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits - May 15th, 2013 10:11 pm Is AstraZeneca Gearing Up for a Shopping Spree? - May 15th, 2013 8:08 am Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert - May 13th, 2013 5:08 am Shire's New Rare Disease Deal: Interesting Science Meets Unique Financing - May 13th, 2013 3:47 am SHIRE PLC Financials - May 11th, 2013 11:04 am SHIRE PLC Financials - May 11th, 2013 11:04 am SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits - May 10th, 2013 2:37 am Shire (SHPG) Shares Cross Above 200 DMA - May 9th, 2013 2:47 pm Shire jumps after drug patent win - May 9th, 2013 1:26 pm Shire Rises On Unusually High Volume (SHPG) - May 9th, 2013 12:09 pm Shire Wins Patent Trial Against Watson Concerning LIALDA® - May 9th, 2013 10:20 am SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits - May 9th, 2013 3:48 am SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - May 8th, 2013 3:51 am View All Current Headlines >>